Telix Pharmaceuticals Ltd (TLX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 09-2000 | |
| Sales | 3,598 | 2,440 | 137 | N/A | N/A |
| Cost of Goods | 1,556 | 1,780 | N/A | N/A | N/A |
| Gross Profit | 2,042 | 659 | 137 | N/A | N/A |
| Operating Expenses | 40,320 | 28,842 | 19,612 | 5,085 | 273 |
| Operating Income | -38,278 | -28,182 | -19,475 | -5,085 | -273 |
| Interest Expense | 903 | 1,686 | 20 | 7 | N/A |
| Other Income | 2,327 | 8,080 | 8,426 | 118 | 3 |
| Pre-tax Income | -36,855 | -21,788 | -11,069 | -4,974 | -270 |
| Income Tax | -2,343 | -2,279 | -1,327 | 0 | N/A |
| Net Income Continuous | -34,512 | -19,509 | -9,742 | -4,974 | -270 |
| Net Income | $-34,512 | $-19,509 | $-9,742 | $-4,974 | $-270 |
| EPS Basic Total Ops | -0.13 | -0.08 | -0.05 | -0.04 | -0.01 |
| EPS Basic Continuous Ops | -0.13 | -0.08 | -0.05 | -0.04 | -0.01 |
| EPS Diluted Total Ops | -0.13 | -0.08 | -0.05 | -0.04 | -0.01 |
| EPS Diluted Continuous Ops | -0.13 | -0.08 | -0.05 | -0.04 | -0.01 |
| EBITDA(a) | $-32,198 | $-17,137 | $-11,048 | $-4,967 | $-273 |